LENSAR, Inc.

Report azionario NasdaqCM:LNSR

Capitalizzazione di mercato: US$72.0m

LENSAR Crescita futura

Criteri Future verificati 2/6

Si prevede che gli utili di LENSAR diminuiranno del 68.2% all'anno, mentre si prevede che il fatturato annuo crescerà del 21.1% all'anno. Si prevede che l'EPS diminuirà del 86.1% all'anno.

Informazioni chiave

-68.2%

Tasso di crescita degli utili

-86.08%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili16.1%
Tasso di crescita dei ricavi21.1%
Rendimento futuro del capitale proprion/a
Copertura analitica

Low

Ultimo aggiornamento08 May 2026

Aggiornamenti recenti sulla crescita futura

Recent updates

Aggiornamento della narrazione May 04

LNSR: Buy Thesis Will Rebuild Around Post Deal Selloff And Adoption Reacceleration

Analysts have nudged their price target on LENSAR stock to $8.50, with recent upgrades to Buy and renewed confidence around the ALLY System adoption story cited as key reasons for the updated view. Analyst Commentary Recent research has focused on how the ALLY System adoption story and the fallout from the halted Alcon acquisition are shaping expectations for LENSAR’s execution and valuation.
Aggiornamento della narrazione Apr 19

LNSR: Buy Thesis Rebuilds Around Post Deal Selloff And Adoption Reacceleration

Analysts have raised their price targets on LENSAR shares to $10, citing renewed optimism around ALLY System adoption and viewing the post acquisition setback selloff as a second chance for investors. Analyst Commentary Bullish Takeaways Bullish analysts point to a $10 price target as a simple yardstick for how they frame upside potential if ALLY System adoption trends seen before the Alcon deal announcement can be re established.
Nuova narrazione Apr 17

Cataract Procedure Bundling Will Pressure Margins Yet Recurring Revenue Should Support Gradual Recovery

Catalysts About LENSAR LENSAR develops and commercializes robotic femtosecond laser systems for cataract surgery, with a focus on its ALLY Robotic Laser Cataract System. What are the underlying business or industry changes driving this perspective?
Aggiornamento della narrazione Apr 03

LNSR: Buy Rating Resets Around Post Deal Selloff And Execution Rebuild

Analysts have trimmed their price target for LENSAR to $8.50 from $12.50, reflecting updated views on revenue growth, profitability and a lower future P/E, while also pointing to recent upgrades that highlight renewed interest in the stock following the failed Alcon acquisition. Analyst Commentary Recent Street research has focused on the reset expectations for LENSAR following the failed Alcon transaction, as well as the potential runway for the company’s ALLY System.
Nuova narrazione Mar 31

Recurring Cataract Procedure Revenue And Machine Learning Will Transform This Undervalued Medical Device Story

Catalysts About LENSAR LENSAR develops and commercializes the ALLY Robotic Laser Cataract System for laser assisted cataract surgery. What are the underlying business or industry changes driving this perspective?
Aggiornamento della narrazione Mar 19

LNSR: Buy Rating And Post Deal Reset Will Drive Future Reassessment

Analysts have trimmed their fair value estimate for LENSAR from $15.00 to $12.50, pointing to revised assumptions around discount rates, margins, and future P/E, alongside a BTIG upgrade to Buy that highlights past ALLY System adoption and the recent post acquisition selloff as a potential second chance for investors to reassess the story. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the cut in fair value to $12.50 still sits above the current $10 price target.
User avatar
Nuova narrazione May 10

Global System Placements Will Improve Operating Room Efficiency

Strong system placements and contract pipelines in international markets enhance potential for sustained revenue growth and competitive advantage.
Articolo di analisi Jan 28

Even With A 28% Surge, Cautious Investors Are Not Rewarding LENSAR, Inc.'s (NASDAQ:LNSR) Performance Completely

Despite an already strong run, LENSAR, Inc. ( NASDAQ:LNSR ) shares have been powering on, with a gain of 28% in the...
Articolo di analisi Dec 24

We're Hopeful That LENSAR (NASDAQ:LNSR) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, LENSAR...
Articolo di analisi Oct 24

Market Might Still Lack Some Conviction On LENSAR, Inc. (NASDAQ:LNSR) Even After 28% Share Price Boost

LENSAR, Inc. ( NASDAQ:LNSR ) shareholders would be excited to see that the share price has had a great month, posting a...
Articolo di analisi Sep 12

LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Articolo di analisi Jul 16

LENSAR, Inc. (NASDAQ:LNSR) Doing What It Can To Lift Shares

With a price-to-sales (or "P/S") ratio of 1.3x LENSAR, Inc. ( NASDAQ:LNSR ) may be sending bullish signals at the...
Articolo di analisi May 01

Here's Why Shareholders May Want To Be Cautious With Increasing LENSAR, Inc.'s (NASDAQ:LNSR) CEO Pay Packet

Key Insights LENSAR to hold its Annual General Meeting on 7th of May Salary of US$541.1k is part of CEO Nick Curtis's...
Articolo di analisi Feb 22

LENSAR, Inc.'s (NASDAQ:LNSR) Shares Leap 33% Yet They're Still Not Telling The Full Story

LENSAR, Inc. ( NASDAQ:LNSR ) shares have continued their recent momentum with a 33% gain in the last month alone...
Articolo di analisi Jan 24

Here's Why We're Watching LENSAR's (NASDAQ:LNSR) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Articolo di analisi Dec 20

Not Many Are Piling Into LENSAR, Inc. (NASDAQ:LNSR) Just Yet

LENSAR, Inc.'s ( NASDAQ:LNSR ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a strong buy right now...
Articolo di analisi Oct 21

Here's Why We're A Bit Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Articolo di analisi Sep 13

Investors Continue Waiting On Sidelines For LENSAR, Inc. (NASDAQ:LNSR)

LENSAR, Inc.'s ( NASDAQ:LNSR ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right now...
Articolo di analisi Mar 21

This Broker Just Slashed Their LENSAR, Inc. (NASDAQ:LNSR) Earnings Forecasts

One thing we could say about the covering analyst on LENSAR, Inc. ( NASDAQ:LNSR ) - they aren't optimistic, having just...
Articolo di analisi Mar 18

Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Articolo di analisi Nov 01

Here's Why We're Not Too Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Seeking Alpha Aug 08

LENSAR GAAP EPS of -$0.67, revenue of $8M

LENSAR press release (NASDAQ:LNSR): Q2 GAAP EPS of -$0.67. Revenue of $8M (+1.3% Y/Y).  Adjusted EBITDA was -$4.3M for the quarter ended June 30, 2022 and -$2.3M for the quarter ended June 30, 2021.  As of June 30, 2022, the company had cash and cash equivalents of $25.2M as compared to $31.6M at December 31, 2021. Based on its cash position and operational forecasts, the company believes it has sufficient cash to fund operations into 2024.
Articolo di analisi Mar 23

LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Articolo di analisi Jul 28

We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Previsioni di crescita degli utili e dei ricavi

NasdaqCM:LNSR - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20281069N/AN/A1
12/31/202773-4N/AN/A2
12/31/20266130N/AN/A2
3/31/20265829-12-12N/A
12/31/202558-34-15-15N/A
9/30/202559-52-12-12N/A
6/30/202558-49-5-5N/A
3/31/202557-57-4-4N/A
12/31/202453-31-2-2N/A
9/30/202449-17-7-6N/A
6/30/202445-14-10-10N/A
3/31/202445-12-9-8N/A
12/31/202342-14-10-10N/A
9/30/202340-13-14-14N/A
6/30/202338-18-19-18N/A
3/31/202334-18-19-19N/A
12/31/202235-20-15-15N/A
9/30/202236-21-11-11N/A
6/30/202237-23-9-8N/A
3/31/202237-21-7-7N/A
12/31/202134-20-9-9N/A
9/30/202132-23-11-10N/A
6/30/202130-21-8-8N/A
3/31/202128-21-12-12N/A
12/31/202026-20-14-14N/A
9/30/202027-15-19-19N/A
6/30/202027-16-22-21N/A
3/31/202029-15-19-17N/A
12/31/201931-15N/A-13N/A
12/31/201824-14N/A-2N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Si prevede che gli utili di LNSR diminuiranno nei prossimi 3 anni ( -68.2% all'anno).

Guadagni vs Mercato: Si prevede che gli utili di LNSR diminuiranno nei prossimi 3 anni ( -68.2% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di LNSR diminuiranno nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di LNSR ( 21.1% all'anno) crescerà più rapidamente del mercato US ( 11.7% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di LNSR ( 21.1% all'anno) crescerà più rapidamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di LNSR è previsto essere elevato tra 3 anni


Scoprire le aziende in crescita

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/05/22 11:57
Prezzo dell'azione a fine giornata2026/05/22 00:00
Utili2026/03/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

LENSAR, Inc. è coperta da 3 analisti. 2 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Michael GormanBTIG
Frank TakkinenLake Street Capital Markets, LLC
Richard NewitterLeerink Partners LLC